المؤلفون: Howard Thom, Iain Bennett, Katy Wilson, Susan C. Edwards, Mick Arber, Kelly Fleetwood, Sydney Toupin, Rachael McCool

المصدر: McCool, R, Wilson, K, Arber, M, Fleetwood, K, Toupin, S, Thom, H, Bennett, I & Edwards, S 2019, ' Systematic review and network meta-analysis comparing ocrelizumab with other treatments for relapsing multiple sclerosis ', Multiple Sclerosis and Related Disorders, vol. 29, pp. 55-61 . https://doi.org/10.1016/j.msard.2018.12.040

مصطلحات موضوعية: medicine.medical_specialty, Network Meta-Analysis, Cochrane Library, Placebo, Antibodies, Monoclonal, Humanized, law.invention, Anti-CD20, 03 medical and health sciences, 0302 clinical medicine, Multiple Sclerosis, Relapsing-Remitting, Randomized controlled trial, law, Internal medicine, medicine, Disease-modifying therapy, Humans, Immunologic Factors, 030212 general & internal medicine, Ocrelizumab, Adverse effect, Network meta-analysis, business.industry, Systematic literature review, General Medicine, Discontinuation, Systematic review, Neurology, Meta-analysis, Relapsing multiple sclerosis, Neurology (clinical), business, 030217 neurology & neurosurgery, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2738be467011732579bfd0eef4469e08
https://pubmed.ncbi.nlm.nih.gov/30677733